Neurologic - Immunovant Sciences GmbH

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05581199

A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Drug

Batoclimab

Phase

Phase II

Condition

Chronic Inflammatory Demyelinating Polyneuropathy CIDP

Keywords

Chronic Inflammatory Demyelinating Polyneuropathy | CIDP